163 related articles for article (PubMed ID: 37941905)
1. Analysis of risk factors for positive surgical margin after laparoscopic radical prostatectomy with and without neoadjuvant hormonal therapy.
Wang F; Zhang G; Tang Y; Wang Y; Li J; Xing N
Front Endocrinol (Lausanne); 2023; 14():1270594. PubMed ID: 37941905
[TBL] [Abstract][Full Text] [Related]
2. Clinical Analysis of Perioperative Outcomes on Neoadjuvant Hormone Therapy before Laparoscopic and Robot-Assisted Surgery for Localized High-Risk Prostate Cancer in a Chinese Cohort.
Sun G; Liang Z; Jiang Y; Ma S; Chen S; Liu R
Curr Oncol; 2022 Nov; 29(11):8668-8676. PubMed ID: 36421336
[TBL] [Abstract][Full Text] [Related]
3. Preoperative red cell distribution width is associated with postoperative lymphovascular invasion in prostate cancer patients treated with radical prostatectomy: A retrospective study.
Wang F; Liang J; Yang F; Liu F; Han S; Xing N
Front Endocrinol (Lausanne); 2022; 13():1020655. PubMed ID: 36313761
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of the impact of 3- versus 8-month neoadjuvant hormonal therapy on outcome of laparoscopic radical prostatectomy.
Pu XY; Wang XH; Wu YL; Wang HP
J Cancer Res Clin Oncol; 2007 Aug; 133(8):555-62. PubMed ID: 17457611
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant hormonal therapy is a feasible option in laparoscopic radical prostatectomy.
Naiki T; Kawai N; Okamura T; Nagata D; Kojima Y; Akita H; Yasui T; Tozawa K; Kohri K
BMC Urol; 2012 Dec; 12():36. PubMed ID: 23249358
[TBL] [Abstract][Full Text] [Related]
6. Laparoscopic radical prostatectomy after neoadjuvant hormonal therapy: an apparently safe and effective procedure.
Brown JA; Garlitz C; Strup SE; Hubosky SG; Gomella L
J Laparoendosc Adv Surg Tech A; 2004 Dec; 14(6):335-8. PubMed ID: 15684777
[TBL] [Abstract][Full Text] [Related]
7. Significant reduction in positive surgical margin rate after laparoscopic radical prostatectomy by application of the modified surgical margin recommendations of the 2009 International Society of Urological Pathology consensus.
Maxeiner A; Magheli A; Jöhrens K; Kilic E; Braun TL; Kempkensteffen C; Hinz S; Stephan C; Miller K; Busch J
BJU Int; 2016 Nov; 118(5):750-757. PubMed ID: 26915345
[TBL] [Abstract][Full Text] [Related]
8. The survival impact of neoadjuvant hormonal therapy before radical prostatectomy for treatment of high-risk prostate cancer.
Tosco L; Laenen A; Briganti A; Gontero P; Karnes RJ; Albersen M; Bastian PJ; Chlosta P; Claessens F; Chun FK; Everaerts W; Gratzke C; Graefen M; Kneitz B; Marchioro G; Salas RS; Tombal B; Van den Broeck T; Moris L; Battaglia A; van der Poel H; Walz J; Bossi A; De Meerleer G; Haustermans K; Van Poppel H; Spahn M; Joniau S
Prostate Cancer Prostatic Dis; 2017 Dec; 20(4):407-412. PubMed ID: 28485390
[TBL] [Abstract][Full Text] [Related]
9. Assessments of Neoadjuvant Hormone Therapy Followed by Robotic-Assisted Radical Prostatectomy for Intermediate- and High-Risk Prostate Cancer.
Hu JC; Hung SC; Ou YC
Anticancer Res; 2017 Jun; 37(6):3143-3150. PubMed ID: 28551656
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant hormonal therapy for low-risk prostate cancer induces biochemical recurrence after radical prostatectomy via increased lymphangiogenesis-related parameters.
Miyata Y; Nakamura Y; Yasuda T; Matsuo T; Ohba K; Furusato B; Fukuoka J; Sakai H
Prostate; 2017 Oct; 77(14):1408-1415. PubMed ID: 28845514
[TBL] [Abstract][Full Text] [Related]
11. Significance of micrometastases in pelvic lymph nodes detected by real-time reverse transcriptase polymerase chain reaction in patients with clinically localized prostate cancer undergoing radical prostatectomy after neoadjuvant hormonal therapy.
Miyake H; Kurahashi T; Hara I; Takenaka A; Fujisawa M
BJU Int; 2007 Feb; 99(2):315-20. PubMed ID: 17155986
[TBL] [Abstract][Full Text] [Related]
12. Update on Memorial Sloan-Kettering Cancer Center studies of neoadjuvant hormonal therapy for prostate cancer.
Fair WR; Betancourt JE
Mol Urol; 2000; 4(3):241-8;discussion 249-50. PubMed ID: 11062380
[TBL] [Abstract][Full Text] [Related]
13. No residual tumor in a radical prostatectomy specimen after neoadjuvant hormonal therapy for localized prostate cancer.
Noguchi M; Noda S; Nakashima O; Kojiro M
Oncol Rep; 2002; 9(5):1075-80. PubMed ID: 12168076
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemohormonal therapy combined with radical prostatectomy and extended PLND for very high risk locally advanced prostate cancer: A retrospective comparative study.
Pan J; Chi C; Qian H; Zhu Y; Shao X; Sha J; Xu F; Wang Y; Karnes RJ; Dong B; Xue W
Urol Oncol; 2019 Dec; 37(12):991-998. PubMed ID: 31466813
[TBL] [Abstract][Full Text] [Related]
15. Effect of total androgen ablation on pathologic stage and resection limit status of prostate cancer. Initial results of the Italian PROSIT study.
Montironi R; Diamanti L; Santinelli A; Galetti-Prayer T; Zattoni F; Selvaggi FP; Pagano F; Bono AV
Pathol Res Pract; 1999; 195(4):201-8. PubMed ID: 10337657
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the rate, location and size of positive surgical margins after laparoscopic and robot-assisted laparoscopic radical prostatectomy.
Kasraeian A; Barret E; Chan J; Sanchez-Salas R; Validire P; Cathelineau X; Rozet F; Galiano M; Vallancien G
BJU Int; 2011 Oct; 108(7):1174-8. PubMed ID: 21392221
[TBL] [Abstract][Full Text] [Related]
17. Comparison of positive surgical margin rates in high risk prostate cancer: open versus minimally invasive radical prostatectomy.
Harty NJ; Kozinn SI; Canes D; Sorcini A; Moinzadeh A
Int Braz J Urol; 2013; 39(5):639-46; discussion 647-8. PubMed ID: 24267107
[TBL] [Abstract][Full Text] [Related]
18. Effect of Neoadjuvant Hormone Therapy on Resection Margin and Survival Prognoses in Locally Advanced Prostate Cancer after Prostatectomy Using Propensity-Score Matching.
Kim SH; Park EY; Joo J; Joung JY; Seo HK; Chung J; Lee KH
Biomed Res Int; 2018; 2018():4307207. PubMed ID: 30627554
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant hormonal therapy prior to radical prostatectomy: the European experience.
Debruyne FM; Witjes WP
Mol Urol; 2000; 4(3):251-6;discussion 257. PubMed ID: 11062381
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant hormonal therapy prior to radical prostatectomy: evaluation of pathological downstaging and biochemical relapse.
Kiriyama I; Ogaki K; Ohba S; Nishimura T
J Nippon Med Sch; 2002 Oct; 69(5):422-7. PubMed ID: 12382001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]